Lyssa Friedman

Ms. Friedman has built and led successful clinical operations teams at multiple diagnostics companies. While leading clinical operations at Seer, she built the clinical operations group with over 40 sites activated in two studies over six months and developed the medical affairs and first product reimbursement strategies. As VP of Clinical Operations at Veracyte, she oversaw clinical studies leading to product launches, pipeline development and positive coverage decisions across the public and private sectors. She provides clinical development and medical affairs consulting services to diagnostic companies across indications, is a frequent speaker on diagnostic development and clinical and regulatory affairs and has authored more than a dozen peer-reviewed publications.